Preview: FibroGen's Earnings
Portfolio Pulse from Benzinga Insights
FibroGen (NASDAQ:FGEN) is set to release its quarterly earnings report on Monday, 2023-08-07. Analysts estimate an EPS of $-0.72. The company's past performance shows a trend of missing EPS estimates and subsequent share price drops. Shares are currently trading at $1.88 and are down 86.82% over the last 52-week period.
August 04, 2023 | 3:46 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
FibroGen's upcoming earnings report could impact its stock price. The company has a history of missing EPS estimates, which has led to share price drops.
FibroGen has a history of missing EPS estimates, which has typically resulted in a drop in share price. Given this trend and the current analyst estimate of $-0.72 EPS, there is a high likelihood that the company's stock price will be negatively impacted following the earnings report.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100